Translate Bio, Inc. is a company in the U.S. stock market and it is a holding in 56 U.S.-traded ETFs. TBIO has around 6.9M shares in the U.S. ETF market. The largest ETF holder of TBIO is the SPDR S&P Biotech ETF (XBI), with approximately 2.18M shares. Investors may also find of interest that the ETF with the largest allocation to TBIO stock is ProShares Merger ETF (MRGR), with a portfolio weight of 2.48%. On average, U.S. ETFs allocate 0.26% of TBIO to their portfolios.
Additionally, TBIO is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with TBIO as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%.